ACCESS TO INNOVATION AND ECONOMIC BURDEN-A CASE OF NON-SMALL CELL LUNG CANCER IN A PATIENT ACCESS PROGRAM IN QINGDAO, CHINA

被引：0
|
作者：
Chen, W. [1 ]
Lin, Y. [1 ]
Zhang, L. [1 ]
机构：
[1] Fudan Univ, Shanghai, Peoples R China
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1368
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN351
引用
收藏
页码：A492 / A492
页数：1
相关论文
共 50 条
  • [41] Geographic Access to Cancer Care and Treatment and Outcomes of Early-Stage Non-Small Cell Lung Cancer
    Shrestha, Pratibha
    Liu, Ying
    Struthers, James
    Kozower, Benjamin
    Lian, Min
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [42] COST AND BURDEN OF NON-SMALL CELL LUNG CANCER'S IN PORTUGAL
    Borges, M.
    Gouveia, M.
    Alarcao, J.
    Sousa, R.
    Teixeira, E.
    Barata, F.
    Laranjeira, E.
    Lopes, F.
    Parente, B.
    Pinheiro, L.
    Vaz-Carneiro, A.
    Costa, J.
    VALUE IN HEALTH, 2014, 17 (07) : A626 - A626
  • [43] Estimation of the Clinical, Economic, and Social Burden of Stage IV Non-Small Cell Lung Cancer in Mexico
    Anorve Bailon, Denisse
    Pico-Guzman, Javier
    Cifuentes, Sergio
    Trejo, Rogelio
    Rodriguez Cid, Jeronimo
    Juarez-Vignon Whaley, Juan Jose
    Heredia Zepeda, Alan Alexis
    Gerson, Raquel
    Camacho-Limas, Christian Patricio
    Martinez-Herrera, Jose Fabian
    Molina, Diana Bonilla
    Camarin Sanchez, Efrain
    Shveid Gerson, Daniela
    PHARMACOECONOMICS-OPEN, 2024, 8 (06) : 869 - 885
  • [44] Efficacy and safety of gefitinib in chemo-naive patients with non-small cell lung cancer (NSCLC) in an expanded access program (EAP).
    Reding, RB
    Natale, R
    Wade, J
    Herbst, R
    Hensing, T
    Belani, CP
    Kelly, K
    Ochs, J
    Govindan, R
    Wozniak, A
    Krebs, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 643S - 643S
  • [45] An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): Data report from Italy
    Tiseo, Marcello
    Gridelli, Cesare
    Cascinu, Stefano
    Crino, Lucio
    Piantedosi, Franco Vito
    Grossi, Francesco
    Brandes, Alba A.
    Labianca, Roberto
    Siena, Salvatore
    Amoroso, Domenico
    Belvedere, Ornella
    Valentino, Brunello
    Bearz, Alessandra
    Venturino, Paola
    Ardizzoni, Andrea
    LUNG CANCER, 2009, 64 (02) : 199 - 206
  • [46] EQUITY OF ACCESS TO NON-SMALL CELL LUNG CANCER SURGERY IN QUEENSLAND: A POPULATION-BASED STUDY
    Dunn, Nathan
    Colquist, Shoni
    Guan, Tracey
    Tran, Nancy
    Windsor, Morgan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 84 - 84
  • [47] Evaluating health disparities in access to genomic testing for metastatic non-small cell lung cancer patients
    Yoon, Brian
    Weeraratne, Dilhan
    Arriaga, Yull Edwin
    Huang, Hu
    Osterman, Travis John
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [48] Nivolumab in a patient with HIV and non-small cell lung cancer
    Hentrich, M.
    Schipek-Voigt, K.
    Jaeger, H.
    Schulz, S.
    Schmid, P.
    Stoetzer, O.
    Bojko, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 232 - 232
  • [49] Treatment of Non-Small Cell Lung Cancer in the Older Patient
    Ganti, Apar Kishor
    deShazo, Mollie
    Weir, Alva B., III
    Hurria, Arti
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (02): : 230 - 239
  • [50] Acquired Hemophilia in an Elderly Patient with Non-Small Cell Lung Cancer: a Case Report
    Antonio Dulcetti
    C. Bruscia
    D. M. Malena
    R. Benvenuto
    A. Martocchia
    A. Sentimentale
    L. Tafaro
    M. Rocchietti March
    P. Martelletti
    SN Comprehensive Clinical Medicine, 5 (1)
12345